Whether transcriptional factors known to be involved in the biogenesis of miR-223 (PU.1, C/EBP, NFI-A) can determine the different expression of miR-223 in serum of AD or PD patients still remains an open question to investigate. Here, SPI1 is linked to Parkinson disease.